Company intelligence / Profile preview

Xenna

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Xenna Corporation is a specialty pharmaceutical company based in Princeton, New Jersey, that focuses on the development and commercialization of topical treatments for skin and nail conditions. The company is best known for its patented products that target keratin-related issues, such as NonyX Nail Gel for clear nails and Calcilo Foot Cream for severe dry skin. Xenna's products are primarily marketed as over-the-counter (OTC) solutions and are distributed through major retail pharmacies and online platforms. The company emphasizes non-toxic, effective formulations for podiatric and dermatological health.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeTopical treatments
Industry: Biotech

Partnerships

WalgreensCVS PharmacyRite AidWalmart

Beyond the preview

Go deeper on Xenna.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xenna.

Explore the full profile